عاجل

INTLJapan thrash Tunisia 4-0 in 1,000th World Cup game INTLIndia's NEET-UG Exam Re-test Amidst Security and Protests AUFamily Concerned for Missing Victorian Man Neville Nicholson AUNRL Sunday Live: Warriors Beat Cowboys, Storm Struggle Against Raiders INTLScammers Exploit Grand Theft Auto VI Hype with Fake Beta Test Offers CNSouth Korea Rushes to Secure Canada's Submarine Deal Worth $39 Billion AUUS Vice President Vance arrives in Switzerland for Iran nuclear talks amid regional tensions INUkrainian Strikes Spark Deepening Fuel Crisis, Rationing Across Russia UKChild Attacked by Crocodile Critical Two Days On: What We Know INTLNetanyahu's Political Demise: A Self-Inflicted Wound on the US-Israel Relationship INTLJapan thrash Tunisia 4-0 in 1,000th World Cup game INTLIndia's NEET-UG Exam Re-test Amidst Security and Protests AUFamily Concerned for Missing Victorian Man Neville Nicholson AUNRL Sunday Live: Warriors Beat Cowboys, Storm Struggle Against Raiders INTLScammers Exploit Grand Theft Auto VI Hype with Fake Beta Test Offers CNSouth Korea Rushes to Secure Canada's Submarine Deal Worth $39 Billion AUUS Vice President Vance arrives in Switzerland for Iran nuclear talks amid regional tensions INUkrainian Strikes Spark Deepening Fuel Crisis, Rationing Across Russia UKChild Attacked by Crocodile Critical Two Days On: What We Know INTLNetanyahu's Political Demise: A Self-Inflicted Wound on the US-Israel Relationship

تسجيل الدخول

METiS TechBio

مستقر3 خبر2 مصادرآخر تحديث: 07.06.2026

وسوم ذات صلةAI cellular reprogramming longevity anti-aging nano-delivery biotech Hong Kong stock market AI-driven drug design

أحدث الأخبار

AI Startup Aims to Reverse Aging by Reprogramming Cells

07.06.2026ملخص الذكاء الاصطناعي

AI Startup Aims to Reverse Aging by Reprogramming Cells

An AI startup has raised $269.5M in an IPO to develop AI-driven nano-delivery systems for cellular reprogramming, aiming to reverse aging by restoring immune cell function, with the US leading global longevity investments at $8.49B in 2024.

METiS TechBio debuts on Hong Kong stock market with 173% surge

13.05.2026ملخص الذكاء الاصطناعي

METiS TechBio debuts on Hong Kong stock market with 173% surge

METiS TechBio's shares surged 173% on their Hong Kong debut, with the AI-driven drug design start-up raising HK$2.11 billion from its initial public offering

METiS TechBio Debuts Strongly on Hong Kong Stock Market, Drawing SpaceX Comparison

13.05.2026ملخص الذكاء الاصطناعي

METiS TechBio Debuts Strongly on Hong Kong Stock Market, Drawing SpaceX Comparison

METiS TechBio, an AI-driven drug design start-up, made a strong debut on the Hong Kong stock market, raising HK$2.11 billion. CEO Lai Tsai-Ta compared the company to SpaceX, highlighting its use of AI algorithms for rapid drug development through nano-delivery platforms.